You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 269 No. 7, February 17, 1993 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Law and Medicine
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Criteria for Evaluating a Ban on the Advertisement of Cigarettes

Balancing Public Health Benefits With Constitutional Burdens

Lawrence O. Gostin, JD; Allan M. Brandt, PhD

JAMA. 1993;269(7):904-909.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE American Medical Association has long recommended a ban on promotional advertising of cigarettes, as has a broad range of public health organizations.1 The tobacco industry, in an uneasy alliance with civil libertarians and the media, argues that a ban would violate the constitutional right to free expression. The debate has been bitter and vehement, impeding adequate examination of the complex public health and constitutional questions engendered by such a policy.

In this article, we offer criteria for evaluating a national ban on tobacco advertising. First, we explore modern case law to determine whether the Supreme Court, applying the commercial free speech doctrine, would uphold a ban. Second, we critically evaluate existing empirical claims about the nature and impact of tobacco advertising on smoking behavior. Third, we assess the unique aspects of the cigarette as a consumer product to see whether it can be distinguished from other hazardous products. . . . [Full Text PDF of this Article]


Author Affiliations

From the American Society of Law, Medicine, and Ethics (Mr Gostin), and the Department of Social Medicine, Harvard Medical School (Dr Brandt), Boston, Mass.


Footnotes

Reprint requests to the Office of the Executive Director, American Society of Law, Medicine, and Ethics, 765 Commonwealth Ave, 16th Floor, Boston, MA 02215 (Mr Gostin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.